Meet the Author

Tomi Shobande

Articles by Tomi Shobande

15.11.2022 | Article

Where are your HCPs?

MSLs are facing an issue of having increasingly limited access to HCPs

By Tomi Shobande

14.11.2022 | Article

Product Launch Tracker: HCPs share optimism for approvals in heart failure, obesity…

HCP's shared the news on product approvals for issues like obesity, multiple myeloma, etc.

By Paul Cranston and Tomi Shobande

05.07.2022 | Article

Product Launch Tracker: HCPs discuss approvals including for the prevention of smallpox…

HCPs also held around the approval of treatments for monkeypox

By Paul Cranston and Tomi Shobande

02.07.2022 | Article

Product Launch Tracker: HCPs celebrate 5th agnostic approval in Cancer alongside other…

with notable excitement being found for the FDA’s approval of Novartis’ 5th agnostic...

By Paul Cranston and Tomi Shobande

06.06.2022 | Article

Product Launch Tracker: HCPs excited by approvals for Eli Lilly, Novartis, Sanofi…

Over the last month, HCPs discussed product approvals for the treatment of a variety...

By Paul Cranston and Tomi Shobande

19.05.2022 | Article

Product Launch Tracker: HCPs excited for BMS’ newly approved ‘Camzyos’

Discover which new drug approvals HCPs are talking about

By Paul Cranston and Tomi Shobande

13.05.2022 | Article

4 key considerations for healthcare market research

The healthcare industry witnessed a paradigm shift since the COVID-19 pandemic began...

By Tomi Shobande

12.04.2022 | Article

Product Launch Tracker: HCPs discuss approvals for several cancer treatments and a…

HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines

By Paul Cranston and Tomi Shobande

11.03.2022 | Article

Product Launch Tracker: Approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk…

HCPs discuss approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk

By Paul Cranston and Tomi Shobande

09.02.2022 | Article

Product Launch Tracker: HCPs celebrate new treatments for metastatic melanoma and non-small…

HCPs also shared the news of approvals of treatments for NSCLC

By Paul Cranston and Tomi Shobande

10.01.2022 | Article

Product Launch Tracker: Pre-Christmas approvals drive HCPs conversations

Discover which new drug approvals dominated HCPs conversations pre-Christmas...

By Paul Cranston and Tomi Shobande

01.12.2021 | Article

Product Launch Tracker: HCPs welcome approvals for MSD’s Keytruda and Takeda’s Livtencity

Discover which new drug approvals HCPs are talking about

By Paul Cranston and Tomi Shobande